Brain interleukin-15 in neuroinflammation and behavior

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 2, 2013, Pages 184-192

  Pan, Weihong ^a   Wu, Xiaojun ^a,c   He, Yi ^a,d   Hsuchou, Hung ^a   Huang, Eagle Yi Kung ^b   Mishra, Pramod K ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d University Beijing   (China)

Author keywords

Anxiety; Cytokine; Depression; Interleukin 15; Memory; Metabolic activity; Neurobehavior; Neurogenesis; Neurotransmitter; Peptide

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLOOXYGENASE 2; ETANERCEPT; FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 15 RECEPTOR GAMMA; INTERLEUKIN 1BETA; INTERLEUKIN 2; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; MINOCYCLINE; PROTEIN C FOS; SEROTONIN; SEROTONIN RECEPTOR; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIDEPRESSANT ACTIVITY; ANXIETY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL ORGANELLE; COGNITIVE DEFECT; DEPRESSION; DRUG PENETRATION; GENE DELETION; GLIOSIS; HOST RESISTANCE; HUMAN; ILLNESS BEHAVIOR; INNATE IMMUNITY; MEMORY CONSOLIDATION; MEMORY DISORDER; MOOD DISORDER; NEOPLASM; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; PSYCHOSIS; REVIEW; SEROTONINERGIC TRANSMISSION; SIDE EFFECT; SIGNAL TRANSDUCTION; SLEEP DISORDER; SUICIDAL IDEATION; THERMOREGULATION; UPREGULATION;

AFFECT; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; HUMANS; INFLAMMATION; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; MEMORY; NEUROGENESIS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84871819986     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.11.009     Document Type: Review

References (81)

1. Aringer M., Stummvoll G.H., Steiner G., Koller M., Steiner C.W., Hofler E., Hiesberger H., Smolen J.S., Graninger W.B. Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology 2001, 40:876-881.
2. Bamford R.N., Battiata A.P., Burton J.D., Sharma H., Waldmann T.A. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region/IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:2897-2902.
3. Barrientos R.M., Higgins E.A., Sprunger D.B., Watkins L.R., Rudy J.W., Maier S.F. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behavioural Brain Research 2002, 134:291-298.
4. Bauer S. Cytokine control of adult neural stem cells. Annals of the New York Academy of Sciences 2009, 1153:48-56.
5. Baune B.T., Wiede F., Braun A., Golledge J., Arolt V., Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:1056-1064.
6. Beck R.D., King M.A., Ha G.K., Cushman J.D., Huang Z., Petitto J.M. IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. Journal of Neuroimmunology 2005, 160:146-153.
7. Beck R.D., Wasserfall C., Ha G.K., Cushman J.D., Huang Z., Atkinson M.A., Petitto J.M. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Research 2005, 1041:223-230.
8. Bergado-Acosta J.R., Sangha S., Narayanan R.T., Obata K., Pape H.C., Stork O. Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory. Learning and Memory 2008, 15:163-171.
9. Budagian V., Bulanova E., Paus R., Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine and Growth Factor Reviews 2006, 17:259-280.
10. Bulfone-Paus S., Bulanova E., Budagian V., Paus R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays 2006, 28:362-377.
11. Burman M.A., Gewirtz J.C. Hippocampal activity, but not plasticity, is required for early consolidation of fear conditioning with a short trace interval. European Journal of Neuroscience 2007, 25:2483-2490.
12. Chierakul W., de F.M., Suputtamongkol Y., Limpaiboon R., Dondorp A., White N.J., van der Poll T. Differential expression of interferon-gamma and interferon-gamma-inducing cytokines in Thai patients with scrub typhus or leptospirosis. Clinical Immunology 2004, 113:140-144.
13. Clement H.W., Buschmann J., Rex S., Grote C., Opper C., Gemsa D., Wesemann W. Effects of interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha on the serotonin metabolism in the nucleus raphe dorsalis of the rat. Journal of Neural Transmission 1997, 104:981-991.
14. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2 -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998, 84:923-933.
15. Corcoran K.A., Desmond T.J., Frey K.A., Maren S. Hippocampal inactivation disrupts the acquisition and contextual encoding of fear extinction. Journal of Neuroscience 2005, 25:8978-8987.
16. Cordero O.J., Salgado F.J., Mera-Varela A., Nogueira M. Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatology International 2001, 21:69-74.
17. Doherty T.M., Seder R.A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. Journal of Immunology 1996, 156:735-741.
18. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
19. Fiore M., Alleva E., Probert L., Kollias G., Angelucci F., Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiology and Behavior 1998, 63:571-576.
20. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal 1994, 13:2822-2830.
21. Gomez-Nicola D., Valle-Argos B., Nieto-Sampedro M. Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 2010, 58:264-276.
22. Gomez-Nicola D., Valle-Argos B., Pallas-Bazarra N., Nieto-Sampedro M. Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Molecular Biology of the Cell 2011, 22:1960-1970.
23. Gomez-Nicola D., Valle-Argos B., Pita-Thomas D.W., Nieto-Sampedro M. Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia 2008, 56:494-505.
24. Goshen I., Kreisel T., Ounallah-Saad H., Renbaum P., Zalzstein Y., Ben-Hur T., Levy-Lahad E., Yirmiya R. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 2007, 32:1106-1115.
25. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
26. Hanisch U.K., Lyons S.A., Prinz M., Nolte C., Weber J.R., Kettenmann H., Kirchhoff F. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. Journal of Biological Chemistry 1997, 272:28853-28860.
27. Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. Journal of Neuroscience 1999, 19:5654-5665.
28. He Y., Hsuchou H., Wu X., Kastin A.J., Khan R.S., Pistell P.J., Wang W.-H., Feng J., Li Z., Guo X., Pan W. Interleukin-15 receptor is essential to facilitate GABA transmission and hippocampal dependent memory. Journal of Neuroscience 2010, 30:4725-4734.
29. He Y., Wu X., Khan R.S., Kastin A.J., Cornélissen G.G., Hsuchou H., Robert B., Halberg F., Pan W. IL15 receptor deletion results in circadian changes of locomotor and metabolic activity. Journal of Molecular Neuroscience 2010, 41:315-321.
30. Heldt S.A., Green A., Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 2004, 29:1610-1619.
31. Hsuchou H., Pan W., Wu X., Kastin A.J. Cessation of blood-to-brain influx of interleukin-15 during development of EAE. Journal of Cerebral Blood Flow and Metabolism 2009, 29:1568-1578.
32. Huang Y.S., Cheng S.N., Chueh S.H., Tsai Y.L., Liou N.H., Guo Y.W., Liao M.H., Shen L.H., Chen C.C., Liu J.C., Ma K.H. Effects of interleukin-15 on neuronal differentiation of neural stem cells. Brain Research 2009, 1304:38-48.
33. Huang Z., Ha G.K., Petitto J.M. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy. Neuroscience Letters 2007, 417:160-164.
34. Ji J., Maren S. Hippocampal involvement in contextual modulation of fear extinction. Hippocampus 2007, 17:749-758.
35. Kastin A.J., Galina Z.H., Horvath A., Olson R.D. Some principles in the peptide field. Journal of Allergy and Clinical Immunology 1987, 79:6-11.
36. Kitaya K., Yasuda J., Yagi I., Tada Y., Fushiki S., Honjo H. IL-15 expression at human endometrium and decidua. Biology of Reproduction 2000, 63:683-687.
37. Kivisakk P., Matusevicius D., He B., Soderstrom M., Fredrikson S., Link H. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clinical and Experimental Immunology 1998, 111:193-197.
38. Klimiuk P.A., Sierakowski S., Latosiewicz R., Cylwik B., Skowronski J., Chwiecko J. Serum cytokines in different histological variants of rheumatoid arthritis. Journal of Rheumatology 2001, 28:1211-1217.
39. Kubota T., Brown R.A., Fang J., Krueger J.M. Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2001, 281:R1004-R1012.
40. Kurowska M., Rudnicka W., Maslinska D., Maslinski W. Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Annals of the New York Academy of Sciences 2002, 966:441-445.
41. Lacosta S., Merali Z., Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behavioral Neuroscience 1999, 113:1030-1041.
42. Lee Y.B., Satoh J., Walker D.G., Kim S.U. Interleukin-15 gene expression in human astrocytes and microglia in culture. NeuroReport 1996, 7:1062-1066.
43. McAfoose J., Koerner H., Baune B.T. The effects of TNF deficiency on age-related cognitive performance. Psychoneuroendocrinology 2009, 34:615-619.
44. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Developmental Neuroscience 1992, 14:1-10.
45. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. Journal of Immunology 1997, 159:2994-2999.
46. Morar B., Schwab S.G., Albus M., Maier W., Lerer B., Wildenauer D.B. Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:318-324.
47. Mossner R., Heils A., Stober G., Okladnova O., Daniel S., Lesch K.P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochemistry International 1998, 33:251-254.
48. Myers K.M., Davis M. Behavioral and neural analysis of extinction. Neuron 2002, 36:567-584.
49. Myint A.M., Schwarz M.J., Steinbusch H.W., Leonard B.E. Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disease 2009, 24:55-68.
50. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. Journal of Neuroscience 2009, 29:4200-4209.
51. Pan W., Ding Y., Yu Y., Ohtaki H., Nakamachi T., Kastin A.J. Stroke upregulates TNF alpha transport across the blood-brain barrier. Experimental Neurology 2006, 198:222-233.
52. Pan W., Hsuchou H., Yu C., Kastin A.J. Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS. Journal of Neurochemistry 2008, 106:313-319.
53. Pan W., Kastin A.J. Upregulation of the transport system for TNFα at the blood-brain barrier. Archives of Physiology and Biochemistry 2001, 109:350-353.
54. Pan W., Kastin A.J., Bell R.L., Olson R.D. Upregulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury. Journal of Neuroscience 1999, 19:3649-3655.
55. Pan W., Kastin A.J., McLay R.N., Rigai T., Pick C.G. Increased hippocampal uptake of TNFα and behavioral changes in mice. Experimental Brain Research 2003, 149:195-199.
56. Pan W., Yu C., Hsuhou H., Khan R.S., Kastin A.J. Cerebral microvascular IL15 is a novel mediator of TNF action. Journal of Neurochemistry 2009, 111:819-827.
57. Petitto J.M., Huang Z., Hartemink D.A., Beck R. IL-2/15 receptor-beta gene deletion alters neurobehavioral performance. Brain Research 2002, 929:218-225.
58. Petitto J.M., McNamara R.K., Gendreau P.L., Huang Z., Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. Journal of Neuroscience Research 1999, 56:441-446.
59. Petrovic-Rackov L., Pejnovic N. Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clinical Rheumatology 2006, 25:448-452.
60. Rachal P.C., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neuroscience and Biobehavioral Reviews 2001, 25:29-41.
61. Rentzos M., Cambouri C., Rombos A., Nikolaou C., Anagnostouli M., Tsoutsou A., Dimitrakopoulos A., Triantafyllou N., Vassilopoulos D. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Journal of the Neurological Sciences 2006, 241:25-29.
62. Saikali P., Antel J.P., Pittet C.L., Newcombe J., Arbour N. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. Journal of Immunology 2010, 185:5693-5703.
63. Satoh J., Kurohara K., Yukitake M., Kuroda Y. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. Journal of the Neurological Sciences 1998, 155:170-177.
64. Schluns K.S., Stoklasek T., Lefrancois L. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both?. International Journal of Biochemistry and Cell Biology 2005, 37:1567-1571.
65. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. Journal of Neuroscience 2005, 25:3219-3228.
66. Stone K.P., Kastin A.J., Pan W. NFκB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell Physiology and Biochemistry 2011, 28:115-124.
67. Takano M., Nishimura H., Kimura Y., Mokuno Y., Washizu J., Itohara S., Nimura Y., Yoshikai Y. Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice. Infection and Immunity 1998, 66:3270-3278.
68. Ueda T., Takeyama Y., Yasuda T., Shinzeki M., Sawa H., Nakajima T., Takase K., Matsumoto I., Fujita T., Ajiki T., Fujino Y., Kuroda Y. Serum interleukin-15 level is a useful predictor of the complications and mortality in severe acute pancreatitis. Surgery 2007, 142:319-326.
69. Umehara T., Udagawa J., Takamura K., Kimura M., Ishimitsu R., Kiyono H., Kawauchi H., Otani H. Role of interleukin-15 in the development of mouse olfactory nerve. Congenital Anomalies (Kyoto) 2009, 49:253-257.
70. Waldmann T., Tagaya Y., Bamford R. Interleukin-2, interleukin-15, and their receptors. International Reviews of Immunology 1998, 16:205-226.
71. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annual Review of Immunology 1999, 17:19-49.
72. Wu X., Hsuchou H., Kastin A.J., He Y., Khan R.S., Stone K.P., Cash M.S., Pan W. Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Ralpha receptor. Psychoneuroendocrinology 2011, 36:266-278.
73. Wu X., Kastin A.J., He Y., Hsuchou H., Rood J.C., Pan W. Essential role of interleukin-15 receptor in normal anxiety behavior. Brain, Behavior, and Immunity 2010, 24:1340-1346.
74. Wu X., Kastin A.J., Hsuchou H., Pan W. The effects of IL2Rgamma knockout on depression and contextual memory. Behavioural Brain Research 2010, 213:319-322.
75. Wu X., Pan W., He Y., Hsuchou H., Kastin A.J. Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2010, 223:65-72.
76. Wu X., Pan W., Stone K.P., Zhang Y., Hsuchou H., Kastin A.J. Expression and signaling of novel IL15Rα splicing variants in cerebral endothelial cells of the blood-brain barrier. Journal of Neurochemistry 2010, 114:122-129.
77. Wuttge D.M., Wildt M., Geborek P., Wollheim F.A., Scheja A., Akesson A. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease. Arthritis Research and Therapy 2007, 9:R85.
78. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., Nabeshima T. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. Journal of Neuroimmunology 2000, 111:131-138.
79. Yirmiya R., Winocur G., Goshen I. Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiology of Learning and Memory 2002, 78:379-389.
80. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
81. Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint A.M., Thuret S., Price J., Pariante C.M. Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012, 37:939-949.